Tertatolol
![]() | |
| Systematic (IUPAC) name | |
|---|---|
|
(±)-1-(tert-Butylamino)-3-(3,4-dihydro-2H-thiochromen-8-yloxy)propan-2-ol | |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Routes of administration | Oral |
| Legal status |
|
| Identifiers | |
| CAS Number |
34784-64-0 |
| ATC code | C07AA16 (WHO) |
| PubChem | CID 36920 |
| IUPHAR/BPS | 571 |
| ChemSpider |
33875 |
| UNII |
9ZO341YQXP |
| KEGG |
D07182 |
| ChEMBL |
CHEMBL434200 |
| Chemical data | |
| Formula | C16H25NO2S |
| Molar mass | 295.44 g/mol |
| Chirality | Racemic mixture |
| |
| |
| | |
Tertatolol (Artex, Artexal, Prenalex) is a medication in the class of beta blockers, used in the treatment of high blood pressure. It was discovered by the French pharmaceutical company Servier and is marketed in Europe.[1]
Tertatolol has also been shown to act as a 5-HT1A receptor antagonist, similarly to pindolol.[2][3]
See also
References
- ↑ Swiss Pharmaceutical Society (2000). Index Nominum 2000: International Drug Directory (Book with CD-ROM). Boca Raton: Medpharm Scientific Publishers. ISBN 3-88763-075-0.
- ↑ Jolas T, Haj-Dahmane S, Lanfumey L, et al. (May 1993). "(-)Tertatolol is a potent antagonist at pre- and postsynaptic serotonin 5-HT1A receptors in the rat brain". Naunyn-Schmiedeberg's Archives of Pharmacology 347 (5): 453–63. doi:10.1007/bf00166735. PMID 7686633.
- ↑ Soudijn, W.; Olivier, Berend; Wijngaarden, I. van (1997). Serotonin receptors and their ligands. Amsterdam: Elsevier. ISBN 0-444-82041-8.
| ||||||||||||||||||||||
This article is issued from Wikipedia - version of the Sunday, April 03, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
